Open AccessOctreotide reverses the resistance of A2780/Pacliaxel ovarian cancer cell line to paclitaxel chemotherapy in vitro
Author(s) -
Yang Shen,
Xiaoyu Zhang,
Xi Chen,
Mulan Ren,
Yefeng Cai
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.151861
Subject(s) - octreotide , somatostatin , somatostatin receptor 2 , apoptosis , paclitaxel , cell growth , flow cytometry , in vitro , endocrinology , immunocytochemistry , western blot , cell culture , messenger rna , medicine , chemistry , biology , microbiology and biotechnology , chemotherapy , somatostatin receptor , biochemistry , gene , genetics
To study the anti-tumor effects of octreotide on A2780/Taxol ovarian cancer cells in vitro, and further explore its potential molecular mechanism.